CUB
I had to take some meds myself after seeing in this report that the MD recieved total remuneration of around $2m last year, and the rest of the executive team and BoD also seem to be getting paid excessively. It is way over what the top WGX boys and girls got for similar level of gold production and probably complexity of operations.
SLR is still feeding off their great deal from their Doray takeover. Mt Monger operations need to be improved, and hopefully Sugar Zone becomes a key profit centre one fine day without costing SLR an arm and leg to get to such a position.
It is SLR's current cash pile that makes it a relatively attractive buy at the current share price/market cap. to me. I am happy with their strategy to spend a heap on exploration short term and have no insight about a possible t/o of GCY etc, which may be attractive to the either party at some price.
If they tried for GCY I doubt that an undervalued WGX would compete with them, but perhaps RMS with its high market cap might use scrip again in a counter off.
loki
- Forums
- ASX - By Stock
- Ann: FY23 Financial Results Summary
CUB I had to take some meds myself after seeing in this report...
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SLR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.42 |
Change
0.018(1.25%) |
Mkt cap ! $1.332B |
Open | High | Low | Value | Volume |
$1.41 | $1.43 | $1.39 | $2.287M | 1.623M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
54 | 54884 | $1.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.43 | 23528 | 40 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
52 | 52678 | 1.420 |
24 | 68455 | 1.415 |
24 | 77960 | 1.410 |
18 | 44941 | 1.405 |
13 | 45675 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.425 | 23460 | 39 |
1.430 | 88304 | 21 |
1.435 | 65695 | 14 |
1.440 | 81770 | 11 |
1.445 | 26172 | 7 |
Last trade - 14.39pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.43 |
  |
Change
0.018 ( 1.39 %) |
|||
Open | High | Low | Volume | ||
$1.41 | $1.43 | $1.39 | 663360 | ||
Last updated 14.59pm 06/05/2024 ? |
Featured News
SLR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online